Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-07-06 @ 2:26 AM
Study NCT ID:
NCT07149259
Status:
RECRUITING
Last Update Posted:
2025-08-29
First Post:
2025-08-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment
Sponsor:
Brooks Rehabilitation
Organization:
Study Overview
Official Title:
Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment
Status:
RECRUITING
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
eSight
Brief Summary:
This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.
Detailed Description:
Subjects will receive introductory training on the controls of the study device at the initial study visit and regular follow-up phone calls once per week from a member of the research staff (e.g., an occupational therapist, or low vision therapist) who is familiar with the study device, to assist with possible troubleshooting as well as device use strategies. You will take the study device home for four weeks to use at school, work, and various daily activities.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: